Come by the Turner MedTech to exhibit booth to learn about Turner MedTech's manufacturing capabilities and a chance to meet with Turner MedTech and KyphoLift™ representatives. The company will ...
For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...
Using wide-angle optical coherence tomography pictures, machine learning algorithms have been trained to identify glaucomatous alterations, including disc degeneration and nerve fibre layer ...
Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...